We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DDOG:NASDAQDatadog, Inc. Analysis

Data as of 2026-05-23 - not real-time

$222.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Datadog is trading at the top of its yearly range, comfortably above its short‑term moving averages. The price sits well above the 20‑day and 50‑day SMA, confirming a bullish technical backdrop. Momentum indicators are strongly positive, with the MACD line crossing above its signal and a widening histogram. However, the RSI has surged into extreme overbought territory, suggesting short‑term price pressure may build. Trading volume has been on a downtrend, which could limit the sustainability of the current rally. A beta above one indicates the stock moves more sharply than the market, amplifying both upside and downside moves. The market sentiment index is in the “Extreme Greed” zone, reflecting heightened investor enthusiasm.
Recent earnings news highlighted revenue breaking the one‑billion‑dollar mark, driven by AI‑focused product adoption and an upgraded full‑year outlook. The company posted a return to GAAP operating profitability and generated robust operating cash flow. Despite these fundamentals, the current price is well above the DCF‑derived fair value, resulting in an overvalued valuation grade. The forward PE remains very high relative to industry peers, while the dividend yield is zero, confirming a non‑dividend‑paying growth profile. Risk considerations include high volatility, sector‑specific competitive pressure, and regulatory scrutiny around data security. Overall, the stock presents a strong growth narrative but at a premium that warrants cautious positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • price above short‑term moving averages
  • bullish MACD crossover
  • RSI in extreme overbought territory

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • strong revenue growth driven by AI
  • robust cash generation and low debt
  • upgraded guidance and operating profitability

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • long‑term demand for observability and security
  • valuation premium relative to DCF
  • high beta and sector competition

Key Metrics & Analysis

Financial Health

Revenue Growth32.20%
Profit Margin3.69%
P/E Ratio555.8
ROE3.93%
ROA-0.22%
Debt/Equity32.22
P/B Ratio19.8
Op. Cash Flow$1.1B
Free Cash Flow$936.7M
Industry P/E39.5

Technical Analysis

TrendBullish
RSI84.0
Support$128.00
Resistance$224.77
MA 20$179.54
MA 50$144.96
MA 200$141.91
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$103.36
Target Price$223.02
Upside/Downside0.31%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.24
Volatility85.21%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.